Skip to main content

Advertisement

SpringerLink
Log in

Tapping the potential of fixed-dose combinations

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Global sales of fixed-dose-combination examples and each individual component.

References

  1. Frantz, S. The trouble with making combination drugs. Nature Rev. Drug Discov. 5, 881–882 (2006).

    Article  Google Scholar 

  2. National Institutes of Health. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute web site [online],; (1997).

  3. Nelson, H. S. et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J. Allergy Clin. Immunology 112, 29–36 (2003).

    Article  CAS  Google Scholar 

  4. Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. AIDSinfo web site [online], (2006).

  5. Berenson, A. Heart pill to be sold by itself. The New York Times (26 July 2006).

    Google Scholar 

  6. Schering–Plough. Press release: Schering–Plough and Merck to develop another new cholesterol lowering medicine. Schering–Plough web site [online] (26 March 2007).

Download references

Author information

Authors and Affiliations

  1. Tara M. Herrick and Ryan P. Million are at Trinity Partners, 100 Park Avenue, Suite 1600, New York 10017, USA.,

    Tara M. Herrick & Ryan P. Million

Authors
  1. Tara M. Herrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryan P. Million
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

DATABASES

Advair

Atripla

Caduet

Symbicort

Vytorin

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrick, T., Million, R. Tapping the potential of fixed-dose combinations. Nat Rev Drug Discov 6, 513–514 (2007). https://doi.org/10.1038/nrd2334

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2334

  • Springer Nature Limited

This article is cited by

Search

Navigation